Aids-associated vacuolar myelopathy and tumor necrosis factor-alpha (TNFα)
暂无分享,去创建一个
B. Gazzard | R. Guiloff | S. V. Tan | D. Henderson | R. Miller | S. Tan
[1] F. Scaravilli,et al. AIDS-associated vacuolar myelopathy. A morphometric study. , 1995, Brain : a journal of neurology.
[2] C. Raine,et al. The adhesion molecule and cytokine profile of multiple sclerosis lesions , 1995, Annals of neurology.
[3] Yao-Tseng Chen,et al. HIV Antigen and DNA in AIDS Spinal Cords Correlate with Macrophage Infiltration but not with Vacuolar Myelopathy , 1993, Journal of neuropathology and experimental neurology.
[4] J. Glass,et al. Cytokine expression of macrophages in HIV‐1‐associated vacuolar myelopathy , 1993, Neurology.
[5] M. Bergmann,et al. AIDS-Myelopathy , 1993, Pathology - Research and Practice.
[6] S. Lederman,et al. The gp120 glycoprotein of HIV‐1 binds to sulfatide and to the myelin associated glycoprotein , 1992, Journal of neuroscience research.
[7] J. Hauw,et al. Neuropathology of the spinal cord in the acquired immunodeficiency syndrome. , 1992, Human pathology.
[8] V. Vullo,et al. Tumour necrosis factor (TNF-alpha) and neurological disorders in HIV infection. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[9] M. Sharief,et al. Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis , 1991 .
[10] D. Dickson,et al. Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. , 1991, Human pathology.
[11] D. Weir,et al. Evidence of brain methyltransferase inhibition and early brain involvement in HIV-positive patients , 1991, The Lancet.
[12] C. Brosnan,et al. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. , 1991, The Journal of clinical investigation.
[13] R. Schiffer,et al. Abnormal vitamin B12 metabolism in human immunodeficiency virus infection. Association with neurological dysfunction. , 1991, Archives of neurology.
[14] J. Sidtis,et al. Quinolinic acid in cerebrospinal fluid and serum in HIV‐1 Infection: Relationship to clinical and neurological status , 1991, Annals of neurology.
[15] D. Giulian,et al. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1 , 1990, Science.
[16] K. Hyland,et al. Cerebrospinal fluid concentrations of S-adenosylmethionine, methionine, and 5-methyltetrahydrofolate in a reference population: cerebrospinal fluid S-adenosylmethionine declines with age in humans. , 1990, Biochemical medicine and metabolic biology.
[17] L. Epstein,et al. Spinal cord disease in children with HIV‐1 infection: a combined molecular biological and neuropathological study * , 1990, Neuropathology and applied neurobiology.
[18] N. Peress,et al. Human immunodeficiency virus type 1 expression in the central nervous system correlates directly with extent of disease. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Artigas,et al. Vacuolar myelopathy in AIDS. A morphological analysis. , 1990, Pathology, research and practice.
[20] K. Hyland,et al. Central-nervous-system methyl-group metabolism in children with neurological complications of HIV infection , 1990, The Lancet.
[21] J. Merrill,et al. Tumor necrosis factor identified in multiple sclerosis brain , 1989, The Journal of experimental medicine.
[22] M. Rosenblum,et al. Dissociation of AIDS‐related vacuolar myelopathy and productive HIV‐1 infection of the spinal cord , 1989, Neurology.
[23] C. Wiley,et al. Spinal cord and peripheral nerve pathology in AIDS: The roles of cytomegalovirus and human immunodeficiency virus , 1989, Annals of neurology.
[24] B. Tavolato,et al. Tumor necrosis factor alpha (TNFα) and neurological diseases Failure in detecting TNFα in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumours , 1989, Journal of Neuroimmunology.
[25] H. Gendelman,et al. Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: expression and replication in macrophages. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[26] R. Price,et al. The AIDS dementia complex. , 1988, The Journal of infectious diseases.
[27] A. Cerami,et al. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses , 1988, The Journal of cell biology.
[28] K. Selmaj,et al. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro , 1988, Annals of neurology.
[29] T. Bottiglieri,et al. Demyelination and decreased S‐adenosylmethionine in 5.10‐methylenetetrahydrofolate reductase deficiency , 1988, Neurology.
[30] D. Newell,et al. In pursuit of evidence based integrated care , 1987, British Journal of Cancer.
[31] B. Navia,et al. Neuropathology of Acquired Immunodeficiency Syndrome (AIDS): An Autopsy Review , 1986, Journal of neuropathology and experimental neurology.
[32] B. Navia,et al. The AIDS dementia complex: II. Neuropathology , 1986, Annals of neurology.
[33] B. Navia,et al. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. , 1985, The New England journal of medicine.
[34] R. Colvin,et al. The immunopathology of experimental allergic encephalomyelitis. I. Quantitative analysis of inflammatory cells in situ. , 1984, Journal of immunology.
[35] J. Riancho,et al. Age-related differences in cytokine secretion. , 1994, Gerontology.
[36] R. Rhodes,et al. Immunohistochemical localization of human immunodeficiency viral antigens in formalin-fixed spinal cords with AIDS myelopathy. , 1989, Clinical neuropathology.